1. Home
  2. KYTX vs IROQ Comparison

KYTX vs IROQ Comparison

Compare KYTX & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYTX
  • IROQ
  • Stock Information
  • Founded
  • KYTX 2018
  • IROQ 1883
  • Country
  • KYTX United States
  • IROQ United States
  • Employees
  • KYTX N/A
  • IROQ N/A
  • Industry
  • KYTX
  • IROQ Savings Institutions
  • Sector
  • KYTX
  • IROQ Finance
  • Exchange
  • KYTX NYSE
  • IROQ Nasdaq
  • Market Cap
  • KYTX 92.1M
  • IROQ 75.8M
  • IPO Year
  • KYTX 2024
  • IROQ 2011
  • Fundamental
  • Price
  • KYTX $2.11
  • IROQ $23.96
  • Analyst Decision
  • KYTX Buy
  • IROQ
  • Analyst Count
  • KYTX 5
  • IROQ 0
  • Target Price
  • KYTX $18.80
  • IROQ N/A
  • AVG Volume (30 Days)
  • KYTX 205.0K
  • IROQ 1.2K
  • Earning Date
  • KYTX 05-16-2025
  • IROQ 04-29-2025
  • Dividend Yield
  • KYTX N/A
  • IROQ 1.67%
  • EPS Growth
  • KYTX N/A
  • IROQ 69.23
  • EPS
  • KYTX N/A
  • IROQ 1.05
  • Revenue
  • KYTX N/A
  • IROQ $25,099,000.00
  • Revenue This Year
  • KYTX N/A
  • IROQ N/A
  • Revenue Next Year
  • KYTX N/A
  • IROQ N/A
  • P/E Ratio
  • KYTX N/A
  • IROQ $22.88
  • Revenue Growth
  • KYTX N/A
  • IROQ 12.02
  • 52 Week Low
  • KYTX $1.78
  • IROQ $14.85
  • 52 Week High
  • KYTX $17.55
  • IROQ $25.76
  • Technical
  • Relative Strength Index (RSI)
  • KYTX 48.82
  • IROQ 50.35
  • Support Level
  • KYTX $1.92
  • IROQ $23.80
  • Resistance Level
  • KYTX $2.38
  • IROQ $24.46
  • Average True Range (ATR)
  • KYTX 0.17
  • IROQ 0.18
  • MACD
  • KYTX 0.02
  • IROQ 0.03
  • Stochastic Oscillator
  • KYTX 41.30
  • IROQ 58.78

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

About IROQ IF Bancorp Inc.

IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others and also a variety of deposit accounts and alternative delivery channels.

Share on Social Networks: